Medicines save lives. Unfortunately the right to profit often overrides the right to access. Fake innovation, manifested in bad patents, harms humanity: it blocks affordable versions of life-saving drugs and impedes real innovation. Too often, the cost of bad intellectual property is the price of life.
Achal Prabhala is determined to change this. As a thoughtful and strategic advocate for intellectual property reform and access to medicines, Achal challenges the legal and policy frameworks that underpin the global development and manufacture of medicines in order to improve access and innovation. The focus of his fellowship is to defend existing pro-access initiatives against onslaughts from private interests, and extend their global reach, especially within India, South Africa and Brazil.
At the heart of our co-investment fellowship model is the principle that Fellows continue to invest in their own ideas. The Foundation amplifies the Fellow’s investment by matching it at least tenfold, along with covering the cost of their time for the year.
The figures you see here do not reflect each Fellow’s fellowship year funding, but rather the funds unlocked within our financial year, as the fellowship years start either March or September and Fellows are not required to spend the available funds proportionately throughout the year.